Acalabrutinib
(Update) Acalabrutinib in CLL and MCL
Obinutuzumab
Update Venetoclax in CLL
ASCO: COVID-19 Medical Resources
NCCN Guidelines for Patients
NCCN COVID-19 Resources Page
Leukemia & Lymphoma Society